Risk Factors and Prognosis of Nontuberculous Mycobacteria Infection in a High Prevalence of Tuberculosis Setting
Abstract
Background: The prevalence and incidence of Non
References
Andr
Baker RG, Hayden MS, Ghosh S (2011). NF?B, inflammation, and metabolic disease. Cell Metabolism, 13(1): 11
Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand Austin A, Gershon AS, Jamieson FB, Marras TK (2017). The risk of mycobacterial infections associated with inhaled corticosteroid use. European Respiratory Journal, 50(3): 1
Diel R, Lipman M, Hoefsloot W (2018). High mortality in patients with Mycobacterium avium complex lung disease: A systematic review. BMC Infectious Diseases. 18(1):206. doi: 10.1186/s12879-018-3113-x.
Fitzpatrick M, Brooks JT, Kaplan JE (2016). Epidemiology of HIV Associated Lung Disease in the United States. Semin Respir Crit Care Med, 37(02): 181
Griffith DE, Aksamit T, Brown-Elliott BA, Ca-tanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, et al. (2007). An official ATS/IDSA statement: Diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine, 175(4): 367
Hinks TS, Wallington JC, Williams AP, Djukanovi? R, Staples KJ, Wilkinson TM (2016). Steroid induced deficiency of mucosal-associated invariant T cells in the chronic obstructive pulmonary disease lung implications for nontypeable haemophilus influenzae infection. American Journal of Respiratory and Critical Care Medicine, 194(10): 1208
Hirose W, Harigai M, Uchiyama T, Itoh K, Ishizuka T, Matsumoto M, Nanki T (2019). Low body mass index and lymphocytopenia associate with Mycobacterium avium complex pulmonary disease in patients with rheumatoid arthritis. Modern Rheumatology, 29(1): 105
Johnson MM, Odell JA (2014). Nontuberculous mycobacterial pulmonary infections. J Thorac Dis. 6(3): 210-20. doi: 10.3978/j.issn.20721439.2013.12.24.
Juita LR, Fauzar (2018). Diagnosis dan tatalaksana penyakit paru nontuberculous (Diagnosis and management of nontuberculous lung disease). Jurnal Kesehatan Andalas. 7(3): 141
Lee H, Myung W, Koh WJ, Moon SM, Jhun BW (2019). Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016. Emerging infectious diseases, 25(3): 569
Lim AYH, Chotirmall SH, Fok ETK, Verma A, De PP, Goh SK, Puah SH, Goh DEL, Abisheganaden JA (2018). Profiling non-tuberculous mycobacteria in an Asian setting: Characteristics and clinical outcomes of hospitalized patients in Singapore. BMC Pulmonary Medicine. 18(1): 1
Maekawa K, Ito Y, Hirai T, Kubo T, Imai S, Tatsumi S, Fujita K, Takakura S, et al. (2011). Environmental risk factors for pulmonary Mycobacterium aviumintracellulare complex disease. Chest. 140(3): 723
Marras TK, Campitelli MA, Kwong JC, Lu H, Brode SK, Marchand-Austin A, Gershon AS, Jamieson FB (2016). Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease. European Respiratory Journal, 48(3): 928
Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S (2016). Epidemiology of pulmonary Nontuberculous mycobacterial disease, Japan. Emerging Infectious Diseases, 22(6): 1116
Patterson CM, Morrison RL, D'Souza A, Teng XS, Happel KI (2012). Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella Pneumoniae in mice. Respiratory Research. 13(1): 40. doi: 10.1186/14659921-13-40.
Saptawati L, Kusumo H, Suryawati B (2019). Prevalence of Non-tuberculous Mycobacteria (NTM) in Surakarta, Indonesia: Higher Than Expected. The 1st International Conference on Health, Technology and Life Sciences. 132
Stout JE, Koh WJ, Yew WW (2016). Update on pulmonary disease due to nontuberculous mycobacteria. International Journal of Infectious Diseases. International Society for Infectious Diseases, 45: 123
